検索
Neurosense Therapeutics Ltd
NRSNウォッチリストに追加
0.723USD
+0.003+0.42%
終値 07/01, 16:00（ET）15分遅れの株価
23.54M時価総額
損失額直近12ヶ月PER
詳細情報 Neurosense Therapeutics Ltd 企業名
NeuroSense Therapeutics Ltd is an Israel-based clinical-stage pharmaceutical company. The Company is active in field of drug development and treatment offers Amyotrophic Lateral Sclerosis (ALS) patients, as well as other neurodegenerative diseases. The Company's lead product candidate, PrimeC, is an oral formulation of a fixed dose combination composed of a specific ratio of drugs. In addition to PrimeC, the Company has initiated research and development efforts in Alzheimer's disease and Parkinson's disease
Neurosense Therapeutics Ltdの企業情報
企業コードNRSN
会社名Neurosense Therapeutics Ltd
上場日Dec 09, 2021
最高経営責任者「CEO」Ben-Noon (Alon)
従業員数15
証券種類Ordinary Share
決算期末Dec 09
本社所在地11 Hamenofim St.
都市HERZLIYA
証券取引所NASDAQ OMX - NASDAQ BASIC
国Israel
郵便番号4672562
電話番号97297996183
ウェブサイトhttps://www.neurosense-tx.com/
企業コードNRSN
上場日Dec 09, 2021
最高経営責任者「CEO」Ben-Noon (Alon)
Neurosense Therapeutics Ltdの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Alon Ben-Noon
Mr. Alon Ben-Noon
Chief Executive Officer, Director
Chief Executive Officer, Director
4.43M
+5.65%
Mr. Or Eisenberg
Mr. Or Eisenberg
Chief Financial Officer
Chief Financial Officer
1.50M
+16.62%
Dr. Ferenc Tracik
Dr. Ferenc Tracik
Chief Medical Officer
Chief Medical Officer
617.63K
+69.30%
Mr. Mark W. Leuchtenberger
Mr. Mark W. Leuchtenberger
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
325.95K
+80.37%
Mr. Cary J. Claiborne
Mr. Cary J. Claiborne
Non-Executive Independent Director
Non-Executive Independent Director
207.90K
+88.46%
Ms. Christine A. Pellizzari, J.D.
Ms. Christine A. Pellizzari, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Caren Deardorf
Ms. Caren Deardorf
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Revital Mandil-Levin, Ph.D.
Dr. Revital Mandil-Levin, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Alon Ben-Noon
Mr. Alon Ben-Noon
Chief Executive Officer, Director
Chief Executive Officer, Director
4.43M
+5.65%
Mr. Or Eisenberg
Mr. Or Eisenberg
Chief Financial Officer
Chief Financial Officer
1.50M
+16.62%
Dr. Ferenc Tracik
Dr. Ferenc Tracik
Chief Medical Officer
Chief Medical Officer
617.63K
+69.30%
Mr. Mark W. Leuchtenberger
Mr. Mark W. Leuchtenberger
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
325.95K
+80.37%
Mr. Cary J. Claiborne
Mr. Cary J. Claiborne
Non-Executive Independent Director
Non-Executive Independent Director
207.90K
+88.46%
Ms. Christine A. Pellizzari, J.D.
Ms. Christine A. Pellizzari, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
よくある質問
Neurosense Therapeutics Ltdの上位5名の株主は誰ですか？
Neurosense Therapeutics Ltdの上位5名の株主は以下のとおりです。Mr. Alon Ben-Noon
Neurosense Therapeutics Ltd（NRSN）の株式を保有している機関の数はいくつですか？
2026Q1時点で、Neurosense Therapeutics Ltdの株式を保有している機関は33社あり、保有株式の総市場価値は約367.79Kで、全体の1.04%を占めています。2025Q4と比較して、機関の持ち株は-2009158.00増加しています。